Trial Profile
Comparing the effect of Simvastatin and gonadotropin-releasing hormone agonist to prevent recurrence of endometriosis.
Status:
Completed
Phase of Trial:
Phase II/III
Latest Information Update: 14 Sep 2016
Price :
$35
*
At a glance
- Drugs Simvastatin (Primary) ; Triptorelin (Primary)
- Indications Endometriosis
- Focus Therapeutic Use
- 01 Oct 2011 New trial record